Burning Rock Biotech (BNR) Current Leases (2020 - 2024)
Historic Current Leases for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $2.3 million.
- Burning Rock Biotech's Current Leases fell 4121.5% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 4121.5%. This contributed to the annual value of $3.4 million for FY2024, which is 17680.92% up from last year.
- Latest data reveals that Burning Rock Biotech reported Current Leases of $2.3 million as of Q3 2025, which was down 4121.5% from $2.7 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Current Leases registered a high of $25.7 million during Q4 2021, and its lowest value of $1.2 million during Q4 2023.
- In the last 5 years, Burning Rock Biotech's Current Leases had a median value of $4.0 million in 2024 and averaged $5.0 million.
- Its Current Leases has fluctuated over the past 5 years, first soared by 338130.08% in 2021, then crashed by 7898.57% in 2022.
- Burning Rock Biotech's Current Leases (Quarter) stood at $25.7 million in 2021, then crashed by 78.99% to $5.4 million in 2022, then plummeted by 77.48% to $1.2 million in 2023, then skyrocketed by 176.81% to $3.4 million in 2024, then tumbled by 30.72% to $2.3 million in 2025.
- Its Current Leases was $2.3 million in Q3 2025, compared to $2.7 million in Q2 2025 and $3.1 million in Q1 2025.